Seeing Is Believing

Currently out of the existing stock ratings of Florent Cespedes, 1 are a HOLD (12.5%), 3 are a SELL (37.5%), 4 are a BUY (50%).
Analyst Florent Cespedes, currently employed at SOCGEN, carries an average stock price target met ratio of 50% that have a potential upside of 18.32% achieved within 345 days.
Florent Cespedes’s has documented 16 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LLY, Eli Lilly and Company at 16-Feb-2023.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 11/3/2020. The price target of $30.79 was fulfilled within 1 day with a profit of $0.83 (2.77%) receiving and performance score of 27.7.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$1290
$214.53 (19.95%)
$1171
22 days ago
(24-Nov-2025)
33/38 (86.84%)
$219.84 (20.54%)
201
Buy
$1150
$74.53 (6.93%)
$1050
28 days ago
(18-Nov-2025)
30/31 (96.77%)
$119.95 (11.65%)
278
Buy
$1165
$89.53 (8.32%)
$885
1 months 3 days ago
(13-Nov-2025)
47/48 (97.92%)
$176.38 (17.84%)
120
Buy
$1500
$424.53 (39.47%)
$1190
1 months 4 days ago
(12-Nov-2025)
1/4 (25%)
$511.38 (51.73%)
437
Buy
$1080
$4.53 (0.42%)
$895
1 months 6 days ago
(10-Nov-2025)
7/8 (87.5%)
$155.63 (16.84%)
138
What Year was the first public recommendation made by Florent Cespedes?